TY - JOUR
T1 - Advanced nutraceutical approaches to Parkinson's disease
T2 - bridging nutrition and neuroprotection
AU - Sharma, Rarchita
AU - Bhate, Lokesh
AU - Agrawal, Yogeeta
AU - Aspatwar, Ashok
N1 - Publisher Copyright:
© 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2025
Y1 - 2025
N2 - Parkinson’s disease (PD) is a neurodegenerative disorder marked by progressive motor symptoms, including tremors, bradykinesia, and postural instability. The disease is characterized by dopaminergic neuron degeneration in the substantia nigra, leading to cognitive decline and motor dysfunction. Dietary supplements, known as nutraceuticals, have numerous health and medical benefits for treating and preventing the disease. Nutraceuticals offer neuroprotection through several mechanisms, including iron chelation, modulation of the cell-signaling pathway, scavenging of superoxide radicals and ROS, and suppression of inflammation. This review highlights the therapeutic potential of nutraceuticals as a complementary approach to traditional pharmaceutical treatments. Nutritional supplements such as Coenzyme Q10, Lycopene, Resveratrol, and Omega-3 fatty acids offer neuroprotection by targeting alpha-synuclein misfolding, oxidative stress, mitochondrial dysfunction, and neuroinflammation, potentially reducing the disease progression and improving patients’ quality of life.
AB - Parkinson’s disease (PD) is a neurodegenerative disorder marked by progressive motor symptoms, including tremors, bradykinesia, and postural instability. The disease is characterized by dopaminergic neuron degeneration in the substantia nigra, leading to cognitive decline and motor dysfunction. Dietary supplements, known as nutraceuticals, have numerous health and medical benefits for treating and preventing the disease. Nutraceuticals offer neuroprotection through several mechanisms, including iron chelation, modulation of the cell-signaling pathway, scavenging of superoxide radicals and ROS, and suppression of inflammation. This review highlights the therapeutic potential of nutraceuticals as a complementary approach to traditional pharmaceutical treatments. Nutritional supplements such as Coenzyme Q10, Lycopene, Resveratrol, and Omega-3 fatty acids offer neuroprotection by targeting alpha-synuclein misfolding, oxidative stress, mitochondrial dysfunction, and neuroinflammation, potentially reducing the disease progression and improving patients’ quality of life.
KW - alpha-synuclein misfolding
KW - Coenzyme Q10 quercetin
KW - ginsenosides
KW - green tea extract EGCG (epigallocatechin-3-gallate)
KW - neuroinflammation
KW - neuroprotection
KW - nutraceuticals
KW - omega-3 polyunsaturated fatty acids
KW - oxidative stress
KW - Parkinson’s disease
KW - resveratrol
U2 - 10.1080/1028415X.2025.2469170
DO - 10.1080/1028415X.2025.2469170
M3 - Review Article
AN - SCOPUS:85218678046
SN - 1028-415X
VL - 28
SP - 1134
EP - 1150
JO - NUTRITIONAL NEUROSCIENCE
JF - NUTRITIONAL NEUROSCIENCE
IS - 9
ER -